COLLAGENASE SANTYL
Drug
Smith+Nephew, Inc.
Total Payments
$1.8M
Transactions
51,742
Doctors
14,054
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $345,737 | 12,926 | 6,119 |
| 2023 | $395,766 | 10,408 | 4,470 |
| 2022 | $473,857 | 12,899 | 5,240 |
| 2021 | $626,998 | 15,509 | 5,761 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $941,395 | 50,738 | 51.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $535,465 | 253 | 29.1% |
| Unspecified | $153,242 | 6 | 8.3% |
| Travel and Lodging | $144,124 | 715 | 7.8% |
| Consulting Fee | $61,170 | 18 | 3.3% |
| Space rental or facility fees (teaching hospital only) | $6,715 | 2 | 0.4% |
| Education | $248.00 | 10 | 0.0% |
Payments by Type
General
$1.7M
51,736 transactions
Research
$153,242
6 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Santyl Human Wound Macrophage Study | Smith+Nephew, Inc. | $153,242 | 0 |
Top Doctors Receiving Payments for COLLAGENASE SANTYL
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Christopher Kim | — | Perth Amboy, NJ | $161,905 | 70 |
| , M.D | Plastic Surgery | Glendale, AZ | $71,536 | 89 |
| , MD | Vascular Surgery | New York, NY | $71,324 | 59 |
| , M.D | Geriatric Medicine | Dallas, TX | $67,497 | 164 |
| , M.D | Specialist | Newark, DE | $62,246 | 140 |
| , DPM | Foot & Ankle Surgery | Boynton Beach, FL | $56,861 | 98 |
| , FNP | Family | Belleville, IL | $48,289 | 149 |
| , DPM | Foot & Ankle Surgery | Fort Collins, CO | $47,504 | 89 |
| , DPM | Podiatrist | Cleveland, OH | $41,331 | 80 |
| , M.D | Specialist | Owings Mills, MD | $35,289 | 102 |
| Paul Glat | — | Bala Cynwyd, PA | $28,289 | 81 |
| , M.D | Clinical & Laboratory Immunology | Fort Worth, TX | $19,030 | 2 |
| , MD | Plastic and Reconstructive Surgery | Englewood, CO | $17,595 | 9 |
| , MD | Undersea and Hyperbaric Medicine | Cheektowaga, NY | $17,210 | 19 |
| , DPM | Foot & Ankle Surgery | Toms River, NJ | $17,172 | 46 |
| , DPM | Podiatrist | Phildelphia, PA | $11,186 | 27 |
| , M.D | Vascular Surgery | Brooklyn, NY | $10,538 | 21 |
| , D.P.M | Podiatrist | Lancaster, CA | $10,489 | 41 |
| , M.D | Plastic Surgery | Pontiac, MI | $10,448 | 59 |
| , DPM | Podiatrist | Denton, TX | $10,428 | 32 |
| , DPM | Foot & Ankle Surgery | Saint Louis, MO | $10,232 | 42 |
| , D.P.M | Public Medicine | Chicago, IL | $10,189 | 26 |
| , MD, MMM | Infectious Disease | Hamilton, NJ | $9,406 | 16 |
| , DPM | Foot & Ankle Surgery | Lexington, KY | $8,984 | 30 |
| , M.D | Undersea and Hyperbaric Medicine | Indianapolis, IN | $8,077 | 10 |
Ad
Manufacturing Companies
- Smith+Nephew, Inc. $1.8M
Product Information
- Type Drug
- Total Payments $1.8M
- Total Doctors 14,054
- Transactions 51,742
About COLLAGENASE SANTYL
COLLAGENASE SANTYL is a drug associated with $1.8M in payments to 14,054 healthcare providers, recorded across 51,742 transactions in the CMS Open Payments database. The primary manufacturer is Smith+Nephew, Inc..
Payment data is available from 2021 to 2024. In 2024, $345,737 was paid across 12,926 transactions to 6,119 doctors.
The most common payment nature for COLLAGENASE SANTYL is "Food and Beverage" ($941,395, 51.1% of total).
COLLAGENASE SANTYL is associated with 1 research study, including "Santyl Human Wound Macrophage Study" ($153,242).